Top

Endocrine

Published in:

01-10-2017 | Meta-Analysis

Association between serum osteocalcin and body mass index: a systematic review and meta-analysis

Authors: Hamed Kord-Varkaneh, Kurosh Djafarian, Masoud khorshidi, Sakineh Shab-Bidar

Published in: Endocrine | Issue 1/2017

Abstract

Purpose

Osteocalcin is considered as a bone-derived hormone affecting on the body fat distribution and body mass index. Several cross-sectional studies have investigated the association between serum osteocalcin and body mass index. The aim of this study was to summarize the evidence on the relationship between serum osteocalcin and body mass index.

Methods

We conducted a complete search up to November 2016 in PubMed and SCOPUS and reviewed reference list of all relevant articles and reviews. The DerSimonian–Laird method were used to pool effect sizes of eligible studies. The potential sources of heterogeneity were assessed using the standard χ ² test.To find possible the sources of between-study heterogeneity, we carried out subgroup analyses based on sex, and type of study population.

Results

There was a significant inverse association in the overall result of this study between serum osteocalcin levels and BMI(r = −0.161; 95% CI: −0.197, −0.124, p < 0.000). In the subgroup analysis to find the sources of significant heterogeneity between-study, we observed that the type of the study population may be the source of between-study heterogeneity and the most correlation was seen in metabolic syndrome studies (r = −0.265; p = 0.000).

Conclusion

Findings from the available data indicated an overall significant inverse association between serum osteocalcin and body mass index. Further studies based on the type of study population are needed to better clarify these associations.

R.J. Kuczmarski, K.M. Flegal, S.M. Campbell, C.L. Johnson, Increasing prevalence of overweight among US adults: the national health and nutrition examination surveys, 1960 to 1991. JAMA 272(3), 205–211 (1994)CrossRefPubMed

L. Khaodhiar, K.C. McCowen, G.L. Blackburn, Obesity and its comorbid conditions. Clin. Cornerstone 2(3), 17–31 (1999)CrossRefPubMed

T.T. Huang, A. Drewnowski, S.K. Kumanyika, T.A. Glass, A systems-oriented multilevel framework for addressing obesity in the 21st century. Prev. Chronic Dis. 6(3), A82 (2009)PubMedPubMedCentral

C.B. Confavreux, R.L. Levine, G. Karsenty, A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms. Mol. Cell. Endocrinol. 310(1), 21–29 (2009)CrossRefPubMedPubMedCentral

Y.-S. Kim, I.-Y. Paik, Y.-J. Rhie, S.-H. Suh, Integrative physiology: defined novel metabolic roles of osteocalcin. J. Korean Med. Sci. 25(7), 985–991 (2010)CrossRefPubMedPubMedCentral

J.R. Villafán-Bernal, S. SáNcHEz-ENRíqUEz, J.F. Muñoz-Valle, Molecular modulation of osteocalcin and its relevance in diabetes (Review). Int. J. Mol. Med. 28(3), 283 (2011)PubMed

A.R. Kang, Y.R. Oh, H.Y. Kim, M.J. Park, B.S. Joo, W.J. Choi, J.Y. Lee, M.H. Jung, Y.I. Ji, J.S. Choi, Up-regulation of inhibitors of DNA binding/differentiation gene during alendronate-induced osteoblast differentiation. Arch. Gynecol. Obstet. 285(5), 1331–1338 (2012)CrossRefPubMed

M. Ferron, E. Hinoi, G. Karsenty, P. Ducy, Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc. Natl. Acad. Sci. 105(13), 5266–5270 (2008)CrossRefPubMedPubMedCentral

N.K. Lee, H. Sowa, E. Hinoi, M. Ferron, J.D. Ahn, C. Confavreux, R. Dacquin, P.J. Mee, M.D. McKee, D.Y. Jung, Endocrine regulation of energy metabolism by the skeleton. Cell 130(3), 456–469 (2007)CrossRefPubMedPubMedCentral

10.

C. Foresta, G. Strapazzon, L. De Toni, L. Gianesello, A. Calcagno, C. Pilon, M. Plebani, R. Vettor, Evidence for osteocalcin production by adipose tissue and its role in human metabolism. J. Clin. Endocrinol. Metabol. 95(7), 3502–3506 (2010)CrossRef

11.

G. Strapazzon, L. De Toni, C. Foresta, Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos. Int. 22(5), 1643–1644 (2011)CrossRefPubMed

12.

M. Zhou, X. Ma, H. Li, X. Pan, J. Tang, Y. Gao, X. Hou, H. Lu, Y. Bao, W. Jia, Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur. J. Endocrinol. 161(5), 723–729 (2009)CrossRefPubMed

13.

A.G. Pittas, S.S. Harris, M. Eliades, P. Stark, B. Dawson-Hughes, Association between serum osteocalcin and markers of metabolic phenotype. J. Clin. Endocrinol. Metabol. 94(3), 827–832 (2009)CrossRef

14.

S. Bae, J. Choe, Y. Chung, B. Kim, S. Lee, H. Kim, J. Koh, H. Kim, G. Kim, The association between serum osteocalcin levels and metabolic syndrome in Koreans. Osteoporos. Int. 22(11), 2837–2846 (2011)CrossRefPubMed

15.

M. El-Eshmawy, I. Abdel Aal, Relationships between preptin and osteocalcin in obese, overweight, and normal weight adults. Appl. Physiol. Nutr. Metabol. 40(3), 218–222 (2015)CrossRef

16.

S.-H. Kim, J.-W. Lee, J.-A. Im, H.-J. Hwang, Serum osteocalcin is related to abdominal obesity in Korean obese and overweight men. Clin. Chim. Acta 411(23), 2054–2057 (2010)CrossRefPubMed

17.

G.S. Caglar, E.D. Ozdemir, M. Kiseli, S. Demirtas, S.D. Cengiz, The association of osteocalcin and adiponectin with glucose metabolism in nondiabetic postmenopausal women. Gynecol. Obstet. Invest. 77(4), 255–260 (2014)CrossRefPubMed

18.

Y. Bao, X. Ma, R. Yang, F. Wang, Y. Hao, J. Dou, H. He, W. Jia, Inverse relationship between serum osteocalcin levels and visceral fat area in Chinese men. J. Clin. Endocrinol. Metabol. 98(1), 345–351 (2012)CrossRef

19.

A. Tan, Y. Gao, X. Yang, H. Zhang, X. Qin, L. Mo, T. Peng, N. Xia, Z. Mo, Low serum osteocalcin level is a potential marker for metabolic syndrome: results from a Chinese male population survey. Metabolism 60(8), 1186–1192 (2011)CrossRefPubMed

20.

Y. Zhang, L. Qi, W. Gu, Q. Yan, M. Dai, J. Shi, Y. Zhai, Y. Chen, J. Liu, W. Wang, Relation of serum osteocalcin level to risk of coronary heart disease in Chinese adults. Am. J. Cardiol. 106(10), 1461–1465 (2010)CrossRefPubMed

21.

L.K. Trento, A. Pietropolli, C. Ticconi, E. Gravotta, M.U. De Martino, A. Fabbri, E. Piccione, Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women. J. Obstet. Gynaecol. Res. 35(1), 152–159 (2009). doi:10.1111/j.1447-0756.2008.00868.x CrossRefPubMed

22.

D.F. Stroup, J.A. Berlin, S.C. Morton, I. Olkin, G.D. Williamson, D. Rennie, D. Moher, B.J. Becker, T.A. Sipe, S.B. Thacker, Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283(15), 2008–2012 (2000)CrossRefPubMed

23.

R.A. Fisher, Frequency distribution of the values of the correlation coefficient in samples from an indefinitely large population. Biometrika 10(4), 507–521 (1915)

24.

J. Higgins, S.G. Thompson, Quantifying heterogeneity in a meta‐analysis. Stat. Med. 21(11), 1539–1558 (2002)CrossRefPubMed

25.

R. DerSimonian, N. Laird, Meta-analysis in clinical trials. Control Clin. Trials 7(3), 177–188 (1986)CrossRefPubMed

26.

M. Liao, X. Guo, X. Yu, G. Pang, S. Zhang, J. Li, A. Tan, Y. Gao, X. Yang, H. Zhang, X. Qin, L. Mo, Z. Lu, C. Wu, Z. Mo, Role of metabolic factors in the association between osteocalcin and testosterone in Chinese men. J. Clin. Endocrinol. Metab. 98(8), 3463–3469 (2013). doi:10.1210/jc.2013-1805 CrossRefPubMed

27.

K. Bezerra dos Santos Magalhaes, M.M. Magalhaes, E.T. Diniz, C.S. Lucena, L. Griz, F. Bandeira, Metabolic syndrome and central fat distribution are related to lower serum osteocalcin concentrations. Ann. Nutr. Metab. 62(3), 183–188 (2013). doi:10.1159/000342561 CrossRefPubMed

28.

M. Liao, L. Huang, Y. Mao, Y. Jiang, Z. Yao, X. Lin, Z. Lu, C. Wu, X. Qin, H. Zhang, Z. Mo, Serum osteocalcin is associated with inflammatory factors in metabolic syndrome: a population-based study in Chinese males. Mediators Inflamm. 2015, 683739 (2015). doi:10.1155/2015/683739 CrossRefPubMedPubMedCentral

29.

Z.M. Gonzalez-Garcia, I.J. Kullo, D.K. Coletta, L.J. Mandarino, G.Q. Shaibi, Osteocalcin and type 2 diabetes risk in Latinos: a life course approach. Am. J. Hum. Biol. 27(6), 859–861 (2015). doi:10.1002/ajhb.22745 CrossRefPubMed

30.

M. El-Eshmawy, I. Abdel Aal, Relationships between preptin and osteocalcin in obese, overweight, and normal weight adults. Appl. Physiol. Nutr. Metab. 40(3), 218–222 (2015). doi:10.1139/apnm-2014-0338 CrossRefPubMed

31.

W.W. Hu, Y.H. Ke, J.W. He, W.Z. Fu, Y.J. Liu, D. Chen, Z.L. Zhang, Serum osteocalcin levels are inversely associated with plasma glucose and body mass index in healthy Chinese women. Acta Pharmacol. Sin. 35(12), 1521–1526 (2014). doi:10.1038/aps.2014.92 CrossRefPubMedPubMedCentral

32.

K.Y. Chin, S. Ima-Nirwana, I.N. Mohamed, F. Ahmad, E.S. Ramli, A. Aminuddin, W.Z. Ngah, Serum osteocalcin is significantly related to indices of obesity and lipid profile in Malaysian men. Int. J. Med. Sci. 11(2), 151–157 (2014). doi:10.7150/ijms.7152 CrossRefPubMedPubMedCentral

33.

H.A. Weiler, J. Lowe, J. Krahn, W.D. Leslie, Osteocalcin and vitamin D status are inversely associated with homeostatic model assessment of insulin resistance in Canadian aboriginal and white women: the first nations bone health study. J. Nutr. Biochem. 24(2), 412–418 (2013). doi:10.1016/j.jnutbio.2011.12.007 CrossRefPubMed

34.

B. Buday, F.P. Pach, B. Literati-Nagy, M. Vitai, Z. Vecsei, L. Koranyi, Serum osteocalcin is associated with improved metabolic state via adiponectin in females versus testosterone in males. Gender specific nature of the bone-energy homeostasis axis. Bone 57(1), 98–104 (2013). doi:10.1016/j.bone.2013.07.018 CrossRefPubMed

35.

36.

S.J. Bae, J.W. Choe, Y.E. Chung, B.J. Kim, S.H. Lee, H.Y. Kim, J.M. Koh, H.K. Kim, G.S. Kim, The association between serum osteocalcin levels and metabolic syndrome in Koreans. Osteoporos. Int. 22(11), 2837–2846 (2011). doi:10.1007/s00198-010-1504-y CrossRefPubMed

37.

Y. Zhang, L. Qi, W. Gu, Q. Yan, M. Dai, J. Shi, Y. Zhai, Y. Chen, J. Liu, W. Wang, G. Ning, J. Hong, Relation of serum osteocalcin level to risk of coronary heart disease in Chinese adults. Am. J. Cardiol. 106(10), 1461–1465 (2010). doi:10.1016/j.amjcard.2010.07.013 CrossRefPubMed

38.

U. Saleem, T.H. Mosley Jr., I.J. Kullo, Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 30(7), 1474–1478 (2010). doi:10.1161/atvbaha.110.204859 CrossRefPubMedPubMedCentral

39.

S.H. Kim, J.W. Lee, J.A. Im, H.J. Hwang, Serum osteocalcin is related to abdominal obesity in Korean obese and overweight men. Clin. Chim. Acta 411(23-24), 2054–2057 (2010). doi:10.1016/j.cca.2010.08.046 CrossRefPubMed

40.

J.M. Kindblom, C. Ohlsson, O. Ljunggren, M.K. Karlsson, A. Tivesten, U. Smith, D. Mellstrom, Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J. Bone Miner. Res. 24(5), 785–791 (2009). doi:10.1359/jbmr.081234 CrossRefPubMed

41.

E.M. Alissa, W.A. Alnahdi, N. Alama, G.A. Ferns, Serum osteocalcin is associated with dietary vitamin D, body weight and serum magnesium in postmenopausal women with and without significant coronary artery disease. Asia Pac. J. Clin. Nutr. 23(2), 246–255 (2014). doi:10.6133/apjcn.2014.23.2.06 PubMed

42.

L. Chen, Q. Li, Z. Yang, Z. Ye, Y. Huang, M. He, J. Wen, X. Wang, B. Lu, J. Hu, C. Liu, C. Ling, S. Qu, R. Hu, Osteocalcin, glucose metabolism, lipid profile and chronic low-grade inflammation in middle-aged and elderly Chinese. Diabet. Med. 30(3), 309–317 (2013). doi:10.1111/j.1464-5491.2012.03769.x CrossRefPubMed

43.

S.W. Lee, H.H. Jo, M.R. Kim, Y.O. You, J.H. Kim, Association between obesity, metabolic risks and serum osteocalcin level in postmenopausal women. Gynecol. Endocrinol. 28(6), 472–477 (2012). doi:10.3109/09513590.2011.633660 CrossRefPubMed

44.

E.F. Papakitsou, A.N. Margioris, K.E. Dretakis, G. Trovas, U. Zoras, G. Lyritis, E.K. Dretakis, K. Stergiopoulos, Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Maturitas 47(3), 185–193 (2004). doi:10.1016/s0378-5122(03)00282-2 CrossRefPubMed

45.

S.W. Lee, H.H. Jo, M.R. Kim, J.H. Kim, Y.O. You, Association between osteocalcin and metabolic syndrome in postmenopausal women. Arch. Gynecol. Obstet. 292(3), 673–681 (2015). doi:10.1007/s00404-015-3656-7 CrossRefPubMed

46.

A. Movahed, B. Larijani, I. Nabipour, M. Kalantarhormozi, K. Asadipooya, K. Vahdat, S. Akbarzadeh, M. Farrokhnia, M. Assadi, R. Amirinejad, A. Bargahi, Z. Sanjdideh, Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: the crosstalk between bone and energy metabolism. J. Bone Miner. Metab. 30(6), 683–691 (2012). doi:10.1007/s00774-012-0367-z CrossRefPubMed

47.

A. Neve, A. Corrado, F.P. Cantatore, Osteocalcin: skeletal and extra‐skeletal effects. J. Cell. Physiol. 228(6), 1149–1153 (2013)CrossRefPubMed

48.

M. Kawai, M.J. Devlin, C.J. Rosen Fat targets for skeletal health.Nat. Rev. Rheumatol. 5(7), 365–372 (2009)CrossRefPubMedPubMedCentral

49.

E. Hinoi, N. Gao, D.Y. Jung, V. Yadav, T. Yoshizawa, M.G. Myers, S.C. Chua, J.K. Kim, K.H. Kaestner, G. Karsenty, The sympathetic tone mediates leptin’s inhibition of insulin secretion by modulating osteocalcin bioactivity. J. Cell. Biol. 183(7), 1235–1242 (2008)CrossRefPubMedPubMedCentral

50.

G. Chamberlain, J. Fox, B. Ashton, J. Middleton, Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25(11), 2739–2749 (2007)CrossRefPubMed

51.

A. Garcia-Martin, M. Cortes-Berdonces, I. Luque-Fernandez, P. Rozas-Moreno, M. Quesada-Charneco, M. Munoz-Torres, Osteocalcin as a marker of metabolic risk in healthy postmenopausal women. Menopause 18(5), 537–541 (2011). doi:10.1097/gme.0b013e3181f8565e CrossRefPubMed

52.

M. Cifuentes, M.A. Johnson, R.D. Lewis, S.B. Heymsfield, H.A. Chowdhury, C.M. Modlesky, S.A. Shapses, Bone turnover and body weight relationships differ in normal-weight compared with heavier postmenopausal women. Osteoporos. Int. 14(2), 116–122 (2003). doi:10.1007/s00198-002-1324-9 CrossRefPubMedPubMedCentral

53.

C. Foresta, G. Strapazzon, L. De Toni, L. Gianesello, A. Bruttocao, A. Scarda, M. Plebani, A. Garolla, Androgens modulate osteocalcin release by human visceral adipose tissue. Clin. Endocrinol. (Oxf). 75(1), 64–69 (2011). doi:10.1111/j.1365-2265.2011.03997.x CrossRefPubMed

54.

55.

A.J. Lucey, G.K. Paschos, I. Thorsdottir, J.A. Martinez, K.D. Cashman, M. Kiely, Young overweight and obese women with lower circulating osteocalcin concentrations exhibit higher insulin resistance and concentrations of C-reactive protein. Nutr. Res. 33(1), 67–75 (2013). doi:10.1016/j.nutres.2012.11.011 CrossRefPubMed

56.

L.E. Polgreen, D.R. Jacobs Jr., B.M. Nathan, J. Steinberger, A. Moran, A.R. Sinaiko, Association of osteocalcin with obesity, insulin resistance, and cardiovascular risk factors in young adults. Obesity (Silver. Spring) 20(11), 2194–2201 (2012). doi:10.1038/oby.2012.108 CrossRef

Title: Association between serum osteocalcin and body mass index: a systematic review and meta-analysis
Authors: Hamed Kord-Varkaneh
Kurosh Djafarian
Masoud khorshidi
Sakineh Shab-Bidar
Publication date: 01-10-2017
Publisher: Springer US
Published in: Endocrine / Issue 1/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-017-1384-4

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2017

Is the hypothalamic–pituitary–adrenal axis disrupted in type 2 diabetes mellitus and is this relevant for bone health?

The roles of microRNA-34b-5p in angiogenesis of thyroid carcinoma

Association of fetuin-A to adiponectin ratio with metabolic syndrome: a cross-sectional study

The impact of peri-operative dexamethasone administration on the normal hypothalamic pituitary adrenal response to major surgical procedures

Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009–2015

Differential diagnosis of pituitary masses at magnetic resonance imaging

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage